Yuqi Zhang
Research Subjects
Yuqi Zhang has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- David N. Beratan
Duke University
9 shared publications Chaoren Liu
Departments of Chemistry, Duke University, Durham, NC, USA
7 shared publicationsPeng Zhang
Departments of Chemistry, Duke University, Durham, NC, USA
6 shared publications- Steven V. Jerome
Schrödinger Inc., 1540 Broadway, 24th floor, New York, New York 10036, United States
4 shared publications Alexander Balaeff
Departments of Chemistry, Duke University, Durham, NC, USA
3 shared publications- Amanda E. Hargrove
Department of Chemical and Physical Science University of Toronto Toronto Ontario Canada
2 shared publications
Latest Publications
- 23 July 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 66 (15) , 9236-9245
Identifying Cryptic Binding Sites with Mixed Solvent MD Simulation and SiteMap
Identifying cryptic binding sites in proteins remains a challenge in structure-based drug discovery because these sites are often not apparent in apo structures. Here, we developed and validated a novel “induce-and-identify” workflow that integrates mixed solvent molecular dynamics (MxMD) simulations with SiteMap. This approach leverages MxMD to sample protein conformations to expose hidden pockets, which are then effectively identified and ranked by SiteMap. Using a challenging data set of 65 cryptic binding sites, the developed workflow identified the cryptic binding site within the top 5 predictions in 78.5% of cases. These results suggest that the proposed MxMD + SiteMap workflow provides a robust and valuable tool for early phase drug discovery, enabling the exploration of a broader range of druggable targets by effectively inducing and identifying cryptic binding sites.
- 23 July 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 66 (15) , 9236-9245
Identifying Cryptic Binding Sites with Mixed Solvent MD Simulation and SiteMap
Identifying cryptic binding sites in proteins remains a challenge in structure-based drug discovery because these sites are often not apparent in apo structures. Here, we developed and validated a novel “induce-and-identify” workflow that integrates mixed solvent molecular dynamics (MxMD) simulations with SiteMap. This approach leverages MxMD to sample protein conformations to expose hidden pockets, which are then effectively identified and ranked by SiteMap. Using a challenging data set of 65 cryptic binding sites, the developed workflow identified the cryptic binding site within the top 5 predictions in 78.5% of cases. These results suggest that the proposed MxMD + SiteMap workflow provides a robust and valuable tool for early phase drug discovery, enabling the exploration of a broader range of druggable targets by effectively inducing and identifying cryptic binding sites.
- 3 December 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Theory and Computation
- Vol. 21 (24) , 12696-12708
Glide WS: Methodology and Initial Assessment of Performance for Docking Accuracy and Virtual Screening
Powered by dramatic advances in computer hardware, the advent of ultralarge make-on-demand virtual libraries, and a shift in small-molecule discovery toward more challenging targets with limited known actives, there has been a growing interest in the development of performant virtual screening methods that can reliably deliver novel hits. We report on a new method called Glide WS, that builds on our earlier efforts (WScore) to introduce an explicit representation of water structure and dynamics to an empirical scoring function suitable for high-throughput docking. This scoring function has been carefully tuned using absolute binding free energy perturbation calculations (ABFEP). Compared with Glide SP, Glide WS offers significant gains in the two primary tasks for molecular docking in drug discovery, pose prediction and virtual screening enrichment. For docking accuracy, Glide WS achieves a self-docking accuracy of 92% on a diverse set of 1477 protein ligand complexes as compared to 85% for Glide SP, using a criterion of 2.5 Å. We also demonstrate significantly improved virtual screening enrichment using a diverse data set covering of 38 targets together with three different computationally generated libraries of decoys, combined with standard known ChEMBL actives. We focus on ligands ranked in the top few percent of the database (the subset that is relevant to practical virtual screening efforts) and demonstrate that, along with improved enrichment of ChEMBL actives, Glide WS achieves a remarkable reduction in the number of poorly scoring decoys (as calibrated by ABFEP calculations), across a high percentage of targets, as compared to Glide SP. These results suggest that considerably higher hit rates will be observed, as compared to conventional rigid receptor docking, in practical virtual screening applications.
- 3 December 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Theory and Computation
- Vol. 21 (24) , 12696-12708
Glide WS: Methodology and Initial Assessment of Performance for Docking Accuracy and Virtual Screening
Powered by dramatic advances in computer hardware, the advent of ultralarge make-on-demand virtual libraries, and a shift in small-molecule discovery toward more challenging targets with limited known actives, there has been a growing interest in the development of performant virtual screening methods that can reliably deliver novel hits. We report on a new method called Glide WS, that builds on our earlier efforts (WScore) to introduce an explicit representation of water structure and dynamics to an empirical scoring function suitable for high-throughput docking. This scoring function has been carefully tuned using absolute binding free energy perturbation calculations (ABFEP). Compared with Glide SP, Glide WS offers significant gains in the two primary tasks for molecular docking in drug discovery, pose prediction and virtual screening enrichment. For docking accuracy, Glide WS achieves a self-docking accuracy of 92% on a diverse set of 1477 protein ligand complexes as compared to 85% for Glide SP, using a criterion of 2.5 Å. We also demonstrate significantly improved virtual screening enrichment using a diverse data set covering of 38 targets together with three different computationally generated libraries of decoys, combined with standard known ChEMBL actives. We focus on ligands ranked in the top few percent of the database (the subset that is relevant to practical virtual screening efforts) and demonstrate that, along with improved enrichment of ChEMBL actives, Glide WS achieves a remarkable reduction in the number of poorly scoring decoys (as calibrated by ABFEP calculations), across a high percentage of targets, as compared to Glide SP. These results suggest that considerably higher hit rates will be observed, as compared to conventional rigid receptor docking, in practical virtual screening applications.
- Open Access
- 11 August 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Glide WS: Methodology and Initial Assessment of Performance for Docking Accuracy and Virtual Screening
Powered by dramatic advances in computer hardware, the advent of ultra-large make-on-demand virtual libraries, and a shift in small molecule discovery toward more challenging targets with limited known actives, there has been a growing interest in the development of performant virtual screening methods that can reliably deliver novel hits. We report on a new method called Glide WS, that builds on our earlier efforts (WScore) to introduce an explicit representation of water structure and dynamics to an empirical scoring function suitable for high-throughput docking. This scoring function has been carefully tuned using Absolute Binding Free Energy Perturbation calculations (ABFEP). Compared with Glide SP, Glide WS offers significant gains in the two primary tasks for molecular docking in drug discovery, pose prediction and virtual screening enrichment. For docking accuracy, Glide WS achieves a self-docking accuracy of 92% on a diverse set of 1477 protein ligand complexes as compared to only 85% for Glide SP, using a criterion of 2.5 Å. We also demonstrate significantly improved virtual screening enrichment using a diverse dataset covering of 38 targets together with three different computationally generated libraries of decoys, combined with standard known ChEMBL actives). We focus ligands ranked in the top few percent of the database (the subset that is relevant to practical virtual screening efforts) and demonstrate that, along with improved enrichment of ChEMBL actives, Glide WS achieves a remarkable reduction in the number of poorly scoring decoys (as calibrated by ABFEP calculations), across a high percentage of targets, as compared to Glide SP. These results suggest that considerably higher hit rates will be observed, as compared to conventional rigid receptor docking, in practical virtual screening applications.
- 11 August 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessGlide WS: Methodology and Initial Assessment of Performance for Docking Accuracy and Virtual Screening
Powered by dramatic advances in computer hardware, the advent of ultra-large make-on-demand virtual libraries, and a shift in small molecule discovery toward more challenging targets with limited known actives, there has been a growing interest in the development of performant virtual screening methods that can reliably deliver novel hits. We report on a new method called Glide WS, that builds on our earlier efforts (WScore) to introduce an explicit representation of water structure and dynamics to an empirical scoring function suitable for high-throughput docking. This scoring function has been carefully tuned using Absolute Binding Free Energy Perturbation calculations (ABFEP). Compared with Glide SP, Glide WS offers significant gains in the two primary tasks for molecular docking in drug discovery, pose prediction and virtual screening enrichment. For docking accuracy, Glide WS achieves a self-docking accuracy of 92% on a diverse set of 1477 protein ligand complexes as compared to only 85% for Glide SP, using a criterion of 2.5 Å. We also demonstrate significantly improved virtual screening enrichment using a diverse dataset covering of 38 targets together with three different computationally generated libraries of decoys, combined with standard known ChEMBL actives). We focus ligands ranked in the top few percent of the database (the subset that is relevant to practical virtual screening efforts) and demonstrate that, along with improved enrichment of ChEMBL actives, Glide WS achieves a remarkable reduction in the number of poorly scoring decoys (as calibrated by ABFEP calculations), across a high percentage of targets, as compared to Glide SP. These results suggest that considerably higher hit rates will be observed, as compared to conventional rigid receptor docking, in practical virtual screening applications.
- 8 July 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (14) , 7393-7398
Enabling In-Silico Hit Discovery Workflows Targeting RNA with Small Molecules
In this study, we investigated and further improved the performance of SiteMap and Glide on predicting the binding site and ligand poses for ribonucleic acids (RNAs) receptors, achieving accuracy on par or better than the state of art benchmarks. Absolute binding free energy perturbation was also expanded to support RNA receptors, demonstrating strong correlation with experimental binding affinities on a diverse set. These advancements help pave a way forward for improved structure-based drug discovery targeting RNAs.
- 8 July 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (14) , 7393-7398
Enabling In-Silico Hit Discovery Workflows Targeting RNA with Small Molecules
In this study, we investigated and further improved the performance of SiteMap and Glide on predicting the binding site and ligand poses for ribonucleic acids (RNAs) receptors, achieving accuracy on par or better than the state of art benchmarks. Absolute binding free energy perturbation was also expanded to support RNA receptors, demonstrating strong correlation with experimental binding affinities on a diverse set. These advancements help pave a way forward for improved structure-based drug discovery targeting RNAs.
- Open Access
- 23 April 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Enabling in-silico Hit Discovery Workflows Targeting RNA with Small Molecules
Ribonucleic acids (RNAs) are emerging as important drug targets, yet in silico modeling of RNA-small molecule interactions presents unique challenges compared to protein targets. This study evaluates and improves computational tools within the Schrödinger Suite for hit discovery against RNA. We benchmarked and enhanced SiteMap for identifying RNA binding sites, introducing an RNA-specific scoring function that improved site prediction accuracy from 44.4% to 65.3% on a filtered HARIBOSS dataset. We also refined Glide, Schrödinger's molecular docking tool, by rebalancing scoring function weights for RNA systems, resulting in improved pose prediction accuracy to 73.7% on a recently published dataset. Furthermore, we expanded the applicability of absolute binding free energy perturbation (ABFEP) to nucleic acid receptors, demonstrating good correlation with experimental binding affinities (RMSE of 1.10 kcal/mol) on a diverse set of 5 RNA-ligand systems. These advancements provide a promising foundation for structure-based drug discovery targeting RNA, although further refinements are needed to achieve performance levels comparable to protein targets, particularly in addressing RNA's dynamic nature and docking into apo receptors.
- 23 April 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessEnabling in-silico Hit Discovery Workflows Targeting RNA with Small Molecules
Ribonucleic acids (RNAs) are emerging as important drug targets, yet in silico modeling of RNA-small molecule interactions presents unique challenges compared to protein targets. This study evaluates and improves computational tools within the Schrödinger Suite for hit discovery against RNA. We benchmarked and enhanced SiteMap for identifying RNA binding sites, introducing an RNA-specific scoring function that improved site prediction accuracy from 44.4% to 65.3% on a filtered HARIBOSS dataset. We also refined Glide, Schrödinger's molecular docking tool, by rebalancing scoring function weights for RNA systems, resulting in improved pose prediction accuracy to 73.7% on a recently published dataset. Furthermore, we expanded the applicability of absolute binding free energy perturbation (ABFEP) to nucleic acid receptors, demonstrating good correlation with experimental binding affinities (RMSE of 1.10 kcal/mol) on a diverse set of 5 RNA-ligand systems. These advancements provide a promising foundation for structure-based drug discovery targeting RNA, although further refinements are needed to achieve performance levels comparable to protein targets, particularly in addressing RNA's dynamic nature and docking into apo receptors.
- 10 March 2023
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 63 (6) , 1656-1667
Benchmarking Refined and Unrefined AlphaFold2 Structures for Hit Discovery
The recently developed AlphaFold2 (AF2) algorithm predicts proteins' 3D structures from amino acid sequences. The open AlphaFold protein structure database covers the complete human proteome. Using an industry-leading molecular docking method (Glide), we investigated the virtual screening performance of 37 common drug targets, each with an AF2 structure and known holo and apo structures from the DUD-E data set. In a subset of 27 targets where the AF2 structures are suitable for refinement, the AF2 structures show comparable early enrichment of known active compounds (avg. EF 1%: 13.0) to apo structures (avg. EF 1%: 11.4) while falling behind early enrichment of the holo structures (avg. EF 1%: 24.2). With an induced-fit protocol (IFD-MD), we can refine the AF2 structures using an aligned known binding ligand as the template to improve the performance in structure-based virtual screening (avg. EF 1%: 18.9). Glide-generated docking poses of known binding ligands can also be used as templates for IFD-MD, achieving similar improvements (avg. EF 1% 18.0). Thus, with proper preparation and refinement, AF2 structures show considerable promise for in silico hit identification.
- 10 March 2023
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 63 (6) , 1656-1667
Benchmarking Refined and Unrefined AlphaFold2 Structures for Hit Discovery
The recently developed AlphaFold2 (AF2) algorithm predicts proteins' 3D structures from amino acid sequences. The open AlphaFold protein structure database covers the complete human proteome. Using an industry-leading molecular docking method (Glide), we investigated the virtual screening performance of 37 common drug targets, each with an AF2 structure and known holo and apo structures from the DUD-E data set. In a subset of 27 targets where the AF2 structures are suitable for refinement, the AF2 structures show comparable early enrichment of known active compounds (avg. EF 1%: 13.0) to apo structures (avg. EF 1%: 11.4) while falling behind early enrichment of the holo structures (avg. EF 1%: 24.2). With an induced-fit protocol (IFD-MD), we can refine the AF2 structures using an aligned known binding ligand as the template to improve the performance in structure-based virtual screening (avg. EF 1%: 18.9). Glide-generated docking poses of known binding ligands can also be used as templates for IFD-MD, achieving similar improvements (avg. EF 1% 18.0). Thus, with proper preparation and refinement, AF2 structures show considerable promise for in silico hit identification.
- 11 September 2019
- Published by American Chemical Society (ACS) in Journal of Chemical Theory and Computation
- Vol. 15 (10) , 5161-5168
Docking Flexible Cyclic Peptides with AutoDock CrankPep
While a new therapeutic cyclic peptide is approved nearly every year, docking large macrocycles has remained challenging. Here, we present a new version of our peptide docking software AutoDock CrankPep (ADCP), extended to dock peptides cyclized through their backbone and/or side chain disulfide bonds. We show that within the top 10 solutions, ADCP identifies the proper interactions for 71% of a data set of 38 complexes, thus making it a useful tool for rational peptide-based drug design.
- 11 September 2019
- Published by American Chemical Society (ACS) in Journal of Chemical Theory and Computation
- Vol. 15 (10) , 5161-5168
Docking Flexible Cyclic Peptides with AutoDock CrankPep
While a new therapeutic cyclic peptide is approved nearly every year, docking large macrocycles has remained challenging. Here, we present a new version of our peptide docking software AutoDock CrankPep (ADCP), extended to dock peptides cyclized through their backbone and/or side chain disulfide bonds. We show that within the top 10 solutions, ADCP identifies the proper interactions for 71% of a data set of 38 complexes, thus making it a useful tool for rational peptide-based drug design.
- 4 June 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (24) , 5121-5127
AutoDock CrankPep: combining folding and docking to predict protein–peptide complexes
Protein–peptide interactions mediate a wide variety of cellular and biological functions. Methods for predicting these interactions have garnered a lot of interest over the past few years, as witnessed by the rapidly growing number of peptide-based therapeutic molecules currently in clinical trials. The size and flexibility of peptides has shown to be challenging for existing automated docking software programs. Here we present AutoDock CrankPep or ADCP in short, a novel approach to dock flexible peptides into rigid receptors. ADCP folds a peptide in the potential field created by the protein to predict the protein–peptide complex. We show that it outperforms leading peptide docking methods on two protein–peptide datasets commonly used for benchmarking docking methods: LEADS-PEP and peptiDB, comprised of peptides with up to 15 amino acids in length. Beyond these datasets, ADCP reliably docked a set of protein–peptide complexes containing peptides ranging in lengths from 16 to 20 amino acids. The robust performance of ADCP on these longer peptides enables accurate modeling of peptide-mediated protein–protein interactions and interactions with disordered proteins. ADCP is distributed under the LGPL 2.0 open source license and is available at http://adcp.scripps.edu. The source code is available at https://github.com/ccsb-scripps/ADCP. Supplementary data are available at Bioinformatics online.
- 4 June 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (24) , 5121-5127
AutoDock CrankPep: combining folding and docking to predict protein–peptide complexes
Protein–peptide interactions mediate a wide variety of cellular and biological functions. Methods for predicting these interactions have garnered a lot of interest over the past few years, as witnessed by the rapidly growing number of peptide-based therapeutic molecules currently in clinical trials. The size and flexibility of peptides has shown to be challenging for existing automated docking software programs. Here we present AutoDock CrankPep or ADCP in short, a novel approach to dock flexible peptides into rigid receptors. ADCP folds a peptide in the potential field created by the protein to predict the protein–peptide complex. We show that it outperforms leading peptide docking methods on two protein–peptide datasets commonly used for benchmarking docking methods: LEADS-PEP and peptiDB, comprised of peptides with up to 15 amino acids in length. Beyond these datasets, ADCP reliably docked a set of protein–peptide complexes containing peptides ranging in lengths from 16 to 20 amino acids. The robust performance of ADCP on these longer peptides enables accurate modeling of peptide-mediated protein–protein interactions and interactions with disordered proteins. ADCP is distributed under the LGPL 2.0 open source license and is available at http://adcp.scripps.edu. The source code is available at https://github.com/ccsb-scripps/ADCP. Supplementary data are available at Bioinformatics online.
- 26 February 2018
- Published by Springer Nature in Nature Nanotechnology
- Vol. 13 (4) , 316-321
Charge splitters and charge transport junctions based on guanine quadruplexes
Self-assembling circuit elements, such as current splitters or combiners at the molecular scale, require the design of building blocks with three or more terminals. A promising material for such building blocks is DNA, wherein multiple strands can self-assemble into multi-ended junctions, and nucleobase stacks can transport charge over long distances. However, nucleobase stacking is often disrupted at junction points, hindering electric charge transport between the two terminals of the junction. Here, we show that a guanine-quadruplex (G4) motif can be used as a connector element for a multi-ended DNA junction. By attaching specific terminal groups to the motif, we demonstrate that charges can enter the structure from one terminal at one end of a three-way G4 motif, and can exit from one of two terminals at the other end with minimal carrier transport attenuation. Moreover, we study four-way G4 junction structures by performing theoretical calculations to assist in the design and optimization of these connectors.
- 26 February 2018
- Published by Springer Nature in Nature Nanotechnology
- Vol. 13 (4) , 316-321
Charge splitters and charge transport junctions based on guanine quadruplexes
Self-assembling circuit elements, such as current splitters or combiners at the molecular scale, require the design of building blocks with three or more terminals. A promising material for such building blocks is DNA, wherein multiple strands can self-assemble into multi-ended junctions, and nucleobase stacks can transport charge over long distances. However, nucleobase stacking is often disrupted at junction points, hindering electric charge transport between the two terminals of the junction. Here, we show that a guanine-quadruplex (G4) motif can be used as a connector element for a multi-ended DNA junction. By attaching specific terminal groups to the motif, we demonstrate that charges can enter the structure from one terminal at one end of a three-way G4 motif, and can exit from one of two terminals at the other end with minimal carrier transport attenuation. Moreover, we study four-way G4 junction structures by performing theoretical calculations to assist in the design and optimization of these connectors.
- 15 August 2017
- Published by Wiley in Angewandte Chemie
- Vol. 129 (43) , 13683-13687
Discovery of Key Physicochemical, Structural, and Spatial Properties of RNA‐Targeted Bioactive Ligands
While a myriad non‐coding RNAs are known to be essential in cellular processes and misregulated in diseases, the development of RNA‐targeted small molecule probes has met with limited success. To elucidate the guiding principles for selective small molecule/RNA recognition, we analyzed cheminformatic and shape‐based descriptors for 104 RNA‐targeted ligands with demonstrated biological activity (RNA‐targeted BIoactive ligaNd Database, R‐BIND). We then compared R‐BIND to both FDA‐approved small molecule drugs and RNA ligands without reported bioactivity. Several striking trends emerged for bioactive RNA ligands, including: 1) Compliance to medicinal chemistry rules, 2) distinctive structural features, and 3) enrichment in rod‐like shapes over others. This work provides unique insights that directly facilitate the selection and synthesis of RNA‐targeted libraries with the goal of efficiently identifying selective small molecule ligands for therapeutically relevant RNAs.
- 15 August 2017
- Published by Wiley in Angewandte Chemie
- Vol. 129 (43) , 13683-13687
Discovery of Key Physicochemical, Structural, and Spatial Properties of RNA‐Targeted Bioactive Ligands
While a myriad non‐coding RNAs are known to be essential in cellular processes and misregulated in diseases, the development of RNA‐targeted small molecule probes has met with limited success. To elucidate the guiding principles for selective small molecule/RNA recognition, we analyzed cheminformatic and shape‐based descriptors for 104 RNA‐targeted ligands with demonstrated biological activity (RNA‐targeted BIoactive ligaNd Database, R‐BIND). We then compared R‐BIND to both FDA‐approved small molecule drugs and RNA ligands without reported bioactivity. Several striking trends emerged for bioactive RNA ligands, including: 1) Compliance to medicinal chemistry rules, 2) distinctive structural features, and 3) enrichment in rod‐like shapes over others. This work provides unique insights that directly facilitate the selection and synthesis of RNA‐targeted libraries with the goal of efficiently identifying selective small molecule ligands for therapeutically relevant RNAs.